Hetero Labs Ltd V Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?
HETERO LABS LTD V has sixty-eight approved drugs.
There are four tentative approvals on HETERO LABS LTD V drugs.
Summary for Hetero Labs Ltd V
| US Patents: | 0 |
| Tradenames: | 64 |
| Ingredients: | 63 |
| NDAs: | 68 |
Drugs and US Patents for Hetero Labs Ltd V
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hetero Labs Ltd V | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205977-002 | Apr 30, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | TOLVAPTAN | tolvaptan | TABLET;ORAL | 205646-001 | Jul 16, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 212414-002 | May 11, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | ENTECAVIR | entecavir | TABLET;ORAL | 205740-001 | Aug 21, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hetero Labs Ltd V | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 204397-002 | Aug 2, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
